If you have bronchiectasis and have needed antibiotics for worsening symptoms or flare-ups in the past year, you might be eligible to try a new inhaled medication called Ensifentrine. We want to see if this medication can help reduce symptoms and prevent flare-ups. You will be compensated for your participation.

Are you currently pregnant and at high risk for early delivery or high blood pressure? We're studying whether a personalized prenatal care program with extra support can help reduce stress and improve outcomes for you and your baby-without extra clinic visits. Compensation included.

Are you a Black Adult interested in lowering your blood pressure? Interested in changing the way you eat? Do you sit too much at work? If you are interested in changing your lifestyle, want to lose some weight, and have a family member that wants to participate with you, you may be able to participate in a research study. Compensation provided.

We know it is hard to find an exercise program that is designed just for you. We have created a new version of an exercise program called the Physical Activity and Community EmPOWERment (PACE) program, an exercise program that helps people be more active. We are looking for people with intellectual disabilities and their caregivers to participate in a research study testing an exercise program.

Do you have incurable, metastatic, or recurrent head and neck squamous cell carcinoma? If so, you may be able to participate in a study to evaluate the addition of the anti-cancer drug, Cetuximab, to standard of care treatment.

Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

If you have a solid tumor that has not responded to other treatments and have no remaining therapy options, you may be eligible for the trial. Participants will receive the study drug at no cost.

If you have non-squamous non-small cell lung cancer and are not currently in treatment, you may qualify for a clinical trial testing a new drug to treat tumors-study drug provided.

Are you newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and looking for treatment options? Our study is evaluating new therapies specifically designed for patients with these conditions. If you have not previously tried an anti-cancer therapy for AML/MDS, this study might be for you!

Do you have a solid tumor that has progressed on other treatments? Do you have at least one measurable tumor? If so, you may be able to take part in a study to improve treatment for advanced solid tumors. We are exploring how safe and effective a combination of drugs is.